nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol valerate/Dienogest—Estrone—prostate cancer	0.139	0.401	CrCtD
Estradiol valerate/Dienogest—Estradiol—prostate cancer	0.105	0.304	CrCtD
Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	0.103	0.296	CrCtD
Estradiol valerate/Dienogest—breast cancer—Estrone—prostate cancer	0.0728	0.324	CpDpCtD
Estradiol valerate/Dienogest—CYP3A4—prostate cancer	0.0727	1	CbGaD
Estradiol valerate/Dienogest—breast cancer—Conjugated Estrogens—prostate cancer	0.0552	0.245	CpDpCtD
Estradiol valerate/Dienogest—breast cancer—Estradiol—prostate cancer	0.0552	0.245	CpDpCtD
Estradiol valerate/Dienogest—breast cancer—Ethinyl Estradiol—prostate cancer	0.0418	0.186	CpDpCtD
Estradiol valerate/Dienogest—Estrone—Estramustine—prostate cancer	0.0216	0.112	CrCrCtD
Estradiol valerate/Dienogest—Estradiol—Estramustine—prostate cancer	0.0216	0.112	CrCrCtD
Estradiol valerate/Dienogest—Ethinyl Estradiol—Estramustine—prostate cancer	0.0205	0.107	CrCrCtD
Estradiol valerate/Dienogest—Estradiol—Estrone—prostate cancer	0.0171	0.0891	CrCrCtD
Estradiol valerate/Dienogest—Ethinyl Estradiol—Estrone—prostate cancer	0.0163	0.0848	CrCrCtD
Estradiol valerate/Dienogest—Estradiol—Conjugated Estrogens—prostate cancer	0.0151	0.0784	CrCrCtD
Estradiol valerate/Dienogest—Estrone—Conjugated Estrogens—prostate cancer	0.0151	0.0784	CrCrCtD
Estradiol valerate/Dienogest—Ethinyl Estradiol—Conjugated Estrogens—prostate cancer	0.0144	0.0747	CrCrCtD
Estradiol valerate/Dienogest—Estrone—Estradiol—prostate cancer	0.013	0.0675	CrCrCtD
Estradiol valerate/Dienogest—Estrone—Ethinyl Estradiol—prostate cancer	0.0127	0.0659	CrCrCtD
Estradiol valerate/Dienogest—Estradiol—Ethinyl Estradiol—prostate cancer	0.0127	0.0659	CrCrCtD
Estradiol valerate/Dienogest—Ethinyl Estradiol—Estradiol—prostate cancer	0.0124	0.0643	CrCrCtD
Estradiol valerate/Dienogest—CYP3A4—Bicalutamide—prostate cancer	0.0121	0.137	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Estramustine—prostate cancer	0.0113	0.127	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Flutamide—prostate cancer	0.01	0.113	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Abiraterone—prostate cancer	0.01	0.113	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Cabazitaxel—prostate cancer	0.00743	0.0839	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Estrone—prostate cancer	0.00726	0.082	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00647	0.0731	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Conjugated Estrogens—prostate cancer	0.00475	0.0537	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Mitoxantrone—prostate cancer	0.00432	0.0488	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Estradiol—prostate cancer	0.00417	0.0471	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Prednisone—prostate cancer	0.00359	0.0405	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Etoposide—prostate cancer	0.00272	0.0308	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Docetaxel—prostate cancer	0.00249	0.0281	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Doxorubicin—prostate cancer	0.00186	0.021	CbGbCtD
Estradiol valerate/Dienogest—Ethinyl Estradiol—AOX1—prostate cancer	0.000135	0.0905	CrCbGaD
Estradiol valerate/Dienogest—Nandrolone phenpropionate—AR—prostate cancer	0.000103	0.0691	CrCbGaD
Estradiol valerate/Dienogest—Estradiol—AOX1—prostate cancer	8.9e-05	0.0597	CrCbGaD
Estradiol valerate/Dienogest—Testosterone Propionate—CYP17A1—prostate cancer	8.78e-05	0.059	CrCbGaD
Estradiol valerate/Dienogest—Nandrolone phenpropionate—CYP19A1—prostate cancer	8.62e-05	0.0579	CrCbGaD
Estradiol valerate/Dienogest—Nandrolone decanoate—AR—prostate cancer	7.8e-05	0.0524	CrCbGaD
Estradiol valerate/Dienogest—Testosterone Propionate—COMT—prostate cancer	7.16e-05	0.0481	CrCbGaD
Estradiol valerate/Dienogest—Nandrolone decanoate—CYP19A1—prostate cancer	6.53e-05	0.0439	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—prostate cancer	5.94e-05	0.0101	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—prostate cancer	5.86e-05	0.00995	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—prostate cancer	5.67e-05	0.00963	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Tamoxifen metabolism—SULT2A1—prostate cancer	5.48e-05	0.00931	CbGpPWpGaD
Estradiol valerate/Dienogest—Ethinyl Estradiol—ESR2—prostate cancer	5.47e-05	0.0367	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Constitutive Androstane Receptor Pathway—CYP3A5—prostate cancer	5.35e-05	0.00908	CbGpPWpGaD
Estradiol valerate/Dienogest—Testosterone Propionate—AR—prostate cancer	5.34e-05	0.0358	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Xenobiotics—CYP2C19—prostate cancer	5.08e-05	0.00862	CbGpPWpGaD
Estradiol valerate/Dienogest—Ethinyl Estradiol—SHBG—prostate cancer	4.99e-05	0.0335	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—prostate cancer	4.98e-05	0.00846	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Xenobiotics—CYP2A6—prostate cancer	4.9e-05	0.00832	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Tamoxifen metabolism—CYP2C19—prostate cancer	4.89e-05	0.00829	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A43—prostate cancer	4.85e-05	0.00823	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Oxidation by Cytochrome P450—CYP3A43—prostate cancer	4.78e-05	0.00812	CbGpPWpGaD
Estradiol valerate/Dienogest—Estrone—ESR2—prostate cancer	4.76e-05	0.032	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—GSTK1—prostate cancer	4.73e-05	0.00803	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—GSTCD—prostate cancer	4.73e-05	0.00803	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Tamoxifen metabolism—CYP2A6—prostate cancer	4.71e-05	0.008	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Tryptophan metabolism—CYP7B1—prostate cancer	4.66e-05	0.00791	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—prostate cancer	4.6e-05	0.00781	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—prostate cancer	4.55e-05	0.00772	CbGpPWpGaD
Estradiol valerate/Dienogest—Estradiol—SLC22A3—prostate cancer	4.53e-05	0.0304	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Estrogen metabolism—NQO1—prostate cancer	4.48e-05	0.00761	CbGpPWpGaD
Estradiol valerate/Dienogest—Estrone—SHBG—prostate cancer	4.34e-05	0.0292	CrCbGaD
Estradiol valerate/Dienogest—Estrone—CYP1B1—prostate cancer	4.34e-05	0.0292	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—prostate cancer	4.33e-05	0.00735	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Estrogen metabolism—CYP1B1—prostate cancer	4.3e-05	0.0073	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Xenobiotics—CYP2E1—prostate cancer	4.17e-05	0.00707	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Tamoxifen metabolism—CYP2E1—prostate cancer	4.01e-05	0.0068	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Aflatoxin activation and detoxification—GGT1—prostate cancer	3.99e-05	0.00677	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A43—prostate cancer	3.93e-05	0.00667	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—prostate cancer	3.91e-05	0.00664	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Tamoxifen metabolism—CYP1B1—prostate cancer	3.8e-05	0.00645	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7B1—prostate cancer	3.77e-05	0.0064	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Estrogen metabolism—COMT—prostate cancer	3.76e-05	0.00638	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—prostate cancer	3.73e-05	0.00634	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Oxidation by Cytochrome P450—CYP7B1—prostate cancer	3.72e-05	0.00631	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—prostate cancer	3.7e-05	0.00628	CbGpPWpGaD
Estradiol valerate/Dienogest—Estradiol—ESR2—prostate cancer	3.61e-05	0.0242	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—prostate cancer	3.58e-05	0.00608	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—prostate cancer	3.49e-05	0.00592	CbGpPWpGaD
Estradiol valerate/Dienogest—Estrone—CYP3A5—prostate cancer	3.46e-05	0.0232	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Estrogen metabolism—GSTM1—prostate cancer	3.44e-05	0.00583	CbGpPWpGaD
Estradiol valerate/Dienogest—Ethinyl Estradiol—ESR1—prostate cancer	3.37e-05	0.0226	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—prostate cancer	3.37e-05	0.00571	CbGpPWpGaD
Estradiol valerate/Dienogest—Estradiol—SHBG—prostate cancer	3.29e-05	0.0221	CrCbGaD
Estradiol valerate/Dienogest—Estradiol—CYP1B1—prostate cancer	3.29e-05	0.0221	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Estrogen metabolism—CYP1A1—prostate cancer	3.26e-05	0.00553	CbGpPWpGaD
Estradiol valerate/Dienogest—Estradiol—SLC22A1—prostate cancer	3.25e-05	0.0218	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A5—prostate cancer	3.23e-05	0.00549	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Oxidation by Cytochrome P450—CYP3A5—prostate cancer	3.19e-05	0.00542	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Tryptophan metabolism—CYP2C18—prostate cancer	3.15e-05	0.00535	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Irinotecan Pathway—APC—prostate cancer	3.12e-05	0.0053	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA2—prostate cancer	3.07e-05	0.00521	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—CYP7B1—prostate cancer	3.06e-05	0.00519	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Xenobiotics—CYP1A1—prostate cancer	2.99e-05	0.00508	CbGpPWpGaD
Estradiol valerate/Dienogest—Estrone—ESR1—prostate cancer	2.93e-05	0.0197	CrCbGaD
Estradiol valerate/Dienogest—Estradiol—AR—prostate cancer	2.89e-05	0.0194	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Tamoxifen metabolism—CYP1A1—prostate cancer	2.88e-05	0.00489	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—prostate cancer	2.86e-05	0.00485	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—prostate cancer	2.73e-05	0.00463	CbGpPWpGaD
Estradiol valerate/Dienogest—Estradiol—CYP3A5—prostate cancer	2.62e-05	0.0176	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A5—prostate cancer	2.62e-05	0.00445	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—prostate cancer	2.59e-05	0.00439	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—prostate cancer	2.55e-05	0.00432	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—prostate cancer	2.51e-05	0.00427	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—prostate cancer	2.46e-05	0.00418	CbGpPWpGaD
Estradiol valerate/Dienogest—Estrone—CYP2E1—prostate cancer	2.38e-05	0.016	CrCbGaD
Estradiol valerate/Dienogest—Estrone—CYP1A1—prostate cancer	2.35e-05	0.0158	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—UGT2B17—prostate cancer	2.34e-05	0.00397	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—UGT2B15—prostate cancer	2.34e-05	0.00397	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—prostate cancer	2.32e-05	0.00393	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—UGT2B17—prostate cancer	2.31e-05	0.00392	CbGpPWpGaD
Estradiol valerate/Dienogest—Estradiol—ESR1—prostate cancer	2.22e-05	0.0149	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—SULT2B1—prostate cancer	2.2e-05	0.00374	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—GSTM3—prostate cancer	2.2e-05	0.00374	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—SULT2B1—prostate cancer	2.17e-05	0.00369	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—GSTM3—prostate cancer	2.17e-05	0.00369	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Tryptophan metabolism—CYP2E1—prostate cancer	2.14e-05	0.00363	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	2.12e-05	0.00361	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—prostate cancer	2.11e-05	0.00358	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—CYP3A43—prostate cancer	2.09e-05	0.00354	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—NAT1—prostate cancer	2.09e-05	0.00354	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—prostate cancer	2.08e-05	0.00353	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—prostate cancer	2.06e-05	0.0035	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—CYP3A43—prostate cancer	2.06e-05	0.00349	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—prostate cancer	2.04e-05	0.00346	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Tryptophan metabolism—CYP1B1—prostate cancer	2.03e-05	0.00344	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—prostate cancer	2.01e-05	0.00341	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	1.95e-05	0.00331	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	1.92e-05	0.00327	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Tryptophan metabolism—CYP19A1—prostate cancer	1.91e-05	0.00324	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	1.86e-05	0.00315	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	1.79e-05	0.00304	CbGpPWpGaD
Estradiol valerate/Dienogest—Estradiol—CYP2C19—prostate cancer	1.78e-05	0.012	CrCbGaD
Estradiol valerate/Dienogest—Estradiol—CYP1A1—prostate cancer	1.78e-05	0.0119	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—EPHX1—prostate cancer	1.75e-05	0.00297	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	1.73e-05	0.00294	CbGpPWpGaD
Estradiol valerate/Dienogest—Ethinyl Estradiol—CYP3A4—prostate cancer	1.72e-05	0.0115	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—prostate cancer	1.71e-05	0.0029	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	1.71e-05	0.0029	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	1.65e-05	0.0028	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	1.64e-05	0.00278	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—CYP7B1—prostate cancer	1.62e-05	0.00276	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	1.62e-05	0.00275	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—CYP7B1—prostate cancer	1.6e-05	0.00272	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—SULT1E1—prostate cancer	1.58e-05	0.00268	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	1.58e-05	0.00268	CbGpPWpGaD
Estradiol valerate/Dienogest—Depression—Capecitabine—prostate cancer	1.58e-05	0.000234	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Ethinyl Estradiol—prostate cancer	1.58e-05	0.000234	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Mitoxantrone—prostate cancer	1.57e-05	0.000232	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	1.56e-05	0.00266	CbGpPWpGaD
Estradiol valerate/Dienogest—Rash—Ethinyl Estradiol—prostate cancer	1.56e-05	0.000232	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Ethinyl Estradiol—prostate cancer	1.56e-05	0.000231	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—SULT1E1—prostate cancer	1.56e-05	0.00265	CbGpPWpGaD
Estradiol valerate/Dienogest—Acute coronary syndrome—Capecitabine—prostate cancer	1.56e-05	0.000231	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Ethinyl Estradiol—prostate cancer	1.55e-05	0.00023	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Capecitabine—prostate cancer	1.55e-05	0.00023	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Prednisone—prostate cancer	1.55e-05	0.00023	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	1.54e-05	0.00262	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Tryptophan metabolism—CYP1A1—prostate cancer	1.54e-05	0.00261	CbGpPWpGaD
Estradiol valerate/Dienogest—Thrombophlebitis—Doxorubicin—prostate cancer	1.53e-05	0.000227	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	1.52e-05	0.00258	CbGpPWpGaD
Estradiol valerate/Dienogest—Anaphylactic shock—Mitoxantrone—prostate cancer	1.51e-05	0.000223	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Mitoxantrone—prostate cancer	1.51e-05	0.000223	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	1.51e-05	0.00256	CbGpPWpGaD
Estradiol valerate/Dienogest—Hypersensitivity—Goserelin—prostate cancer	1.5e-05	0.000223	CcSEcCtD
Estradiol valerate/Dienogest—Estrone—CYP3A4—prostate cancer	1.5e-05	0.0101	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	1.49e-05	0.00253	CbGpPWpGaD
Estradiol valerate/Dienogest—Hypersensitivity—Conjugated Estrogens—prostate cancer	1.49e-05	0.000221	CcSEcCtD
Estradiol valerate/Dienogest—Purpura—Epirubicin—prostate cancer	1.48e-05	0.00022	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Etoposide—prostate cancer	1.48e-05	0.000219	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Ethinyl Estradiol—prostate cancer	1.47e-05	0.000218	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Goserelin—prostate cancer	1.46e-05	0.000217	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Epirubicin—prostate cancer	1.46e-05	0.000216	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Conjugated Estrogens—prostate cancer	1.45e-05	0.000215	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Goserelin—prostate cancer	1.44e-05	0.000214	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Docetaxel—prostate cancer	1.44e-05	0.000214	CcSEcCtD
Estradiol valerate/Dienogest—Weight increased—Prednisone—prostate cancer	1.44e-05	0.000213	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Conjugated Estrogens—prostate cancer	1.43e-05	0.000212	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Prednisone—prostate cancer	1.43e-05	0.000212	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Estradiol—prostate cancer	1.42e-05	0.000211	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Docetaxel—prostate cancer	1.41e-05	0.000209	CcSEcCtD
Estradiol valerate/Dienogest—Migraine—Epirubicin—prostate cancer	1.41e-05	0.000209	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Prednisone—prostate cancer	1.4e-05	0.000208	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	1.4e-05	0.00238	CbGpPWpGaD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Estradiol—prostate cancer	1.4e-05	0.000207	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Capecitabine—prostate cancer	1.39e-05	0.000207	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Estradiol—prostate cancer	1.39e-05	0.000207	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	1.39e-05	0.00236	CbGpPWpGaD
Estradiol valerate/Dienogest—Acute coronary syndrome—Prednisone—prostate cancer	1.39e-05	0.000206	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Docetaxel—prostate cancer	1.39e-05	0.000206	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Estradiol—prostate cancer	1.38e-05	0.000205	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Prednisone—prostate cancer	1.38e-05	0.000205	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	1.37e-05	0.00233	CbGpPWpGaD
Estradiol valerate/Dienogest—Purpura—Doxorubicin—prostate cancer	1.37e-05	0.000203	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Docetaxel—prostate cancer	1.37e-05	0.000203	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Capecitabine—prostate cancer	1.37e-05	0.000203	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Docetaxel—prostate cancer	1.36e-05	0.000202	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Epirubicin—prostate cancer	1.35e-05	0.000201	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Doxorubicin—prostate cancer	1.35e-05	0.0002	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Goserelin—prostate cancer	1.35e-05	0.0002	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—GSTA3—prostate cancer	1.34e-05	0.00228	CbGpPWpGaD
Estradiol valerate/Dienogest—Erythema multiforme—Capecitabine—prostate cancer	1.34e-05	0.000199	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Conjugated Estrogens—prostate cancer	1.34e-05	0.000198	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	1.33e-05	0.00226	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	1.33e-05	0.00225	CbGpPWpGaD
Estradiol valerate/Dienogest—Eye disorder—Capecitabine—prostate cancer	1.33e-05	0.000197	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Mitoxantrone—prostate cancer	1.33e-05	0.000197	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Docetaxel—prostate cancer	1.32e-05	0.000196	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Estradiol—prostate cancer	1.32e-05	0.000196	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Capecitabine—prostate cancer	1.32e-05	0.000195	CcSEcCtD
Estradiol valerate/Dienogest—Migraine—Doxorubicin—prostate cancer	1.3e-05	0.000193	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Mitoxantrone—prostate cancer	1.3e-05	0.000193	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Goserelin—prostate cancer	1.3e-05	0.000192	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Epirubicin—prostate cancer	1.29e-05	0.000191	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Mitoxantrone—prostate cancer	1.29e-05	0.000191	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Goserelin—prostate cancer	1.29e-05	0.000191	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Goserelin—prostate cancer	1.28e-05	0.000191	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Conjugated Estrogens—prostate cancer	1.28e-05	0.00019	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Estradiol—prostate cancer	1.28e-05	0.00019	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Docetaxel—prostate cancer	1.28e-05	0.00019	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Capecitabine—prostate cancer	1.28e-05	0.00019	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Estradiol—prostate cancer	1.28e-05	0.00019	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Goserelin—prostate cancer	1.28e-05	0.000189	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Docetaxel—prostate cancer	1.28e-05	0.000189	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Conjugated Estrogens—prostate cancer	1.27e-05	0.000189	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Conjugated Estrogens—prostate cancer	1.27e-05	0.000189	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	1.27e-05	0.00215	CbGpPWpGaD
Estradiol valerate/Dienogest—Headache—Conjugated Estrogens—prostate cancer	1.27e-05	0.000188	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Etoposide—prostate cancer	1.25e-05	0.000186	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Doxorubicin—prostate cancer	1.25e-05	0.000186	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	1.25e-05	0.00212	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	1.24e-05	0.00211	CbGpPWpGaD
Estradiol valerate/Dienogest—Abdominal distension—Epirubicin—prostate cancer	1.24e-05	0.000184	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Capecitabine—prostate cancer	1.24e-05	0.000184	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Prednisone—prostate cancer	1.24e-05	0.000184	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Capecitabine—prostate cancer	1.24e-05	0.000183	CcSEcCtD
Estradiol valerate/Dienogest—Asthma—Epirubicin—prostate cancer	1.23e-05	0.000183	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Mitoxantrone—prostate cancer	1.23e-05	0.000183	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	1.23e-05	0.00209	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—GSTA4—prostate cancer	1.23e-05	0.00209	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	1.23e-05	0.00208	CbGpPWpGaD
Estradiol valerate/Dienogest—Muscle spasms—Docetaxel—prostate cancer	1.23e-05	0.000182	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Capecitabine—prostate cancer	1.22e-05	0.000181	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	1.21e-05	0.00206	CbGpPWpGaD
Estradiol valerate/Dienogest—Nausea—Goserelin—prostate cancer	1.21e-05	0.00018	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Epirubicin—prostate cancer	1.21e-05	0.00018	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	1.21e-05	0.00205	CbGpPWpGaD
Estradiol valerate/Dienogest—Nausea—Conjugated Estrogens—prostate cancer	1.2e-05	0.000178	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—GSTA2—prostate cancer	1.2e-05	0.00203	CbGpPWpGaD
Estradiol valerate/Dienogest—Urticaria—Mitoxantrone—prostate cancer	1.2e-05	0.000177	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Doxorubicin—prostate cancer	1.19e-05	0.000177	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Estradiol—prostate cancer	1.19e-05	0.000177	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Mitoxantrone—prostate cancer	1.19e-05	0.000177	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Capecitabine—prostate cancer	1.19e-05	0.000176	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	1.18e-05	0.00201	CbGpPWpGaD
Estradiol valerate/Dienogest—Eye disorder—Prednisone—prostate cancer	1.18e-05	0.000175	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	1.17e-05	0.00198	CbGpPWpGaD
Estradiol valerate/Dienogest—Asthenia—Estradiol—prostate cancer	1.16e-05	0.000172	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—GSTA1—prostate cancer	1.16e-05	0.00196	CbGpPWpGaD
Estradiol valerate/Dienogest—Abdominal distension—Doxorubicin—prostate cancer	1.15e-05	0.000171	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Estradiol—prostate cancer	1.14e-05	0.00017	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—NAT2—prostate cancer	1.14e-05	0.00194	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—GSTO1—prostate cancer	1.14e-05	0.00194	CbGpPWpGaD
Estradiol valerate/Dienogest—Asthma—Doxorubicin—prostate cancer	1.14e-05	0.000169	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Prednisone—prostate cancer	1.14e-05	0.000169	CcSEcCtD
Estradiol valerate/Dienogest—Estradiol—CYP3A4—prostate cancer	1.14e-05	0.00762	CrCbGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	1.13e-05	0.00191	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	1.13e-05	0.00191	CbGpPWpGaD
Estradiol valerate/Dienogest—Palpitations—Docetaxel—prostate cancer	1.13e-05	0.000167	CcSEcCtD
Estradiol valerate/Dienogest—Weight increased—Epirubicin—prostate cancer	1.12e-05	0.000167	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Doxorubicin—prostate cancer	1.12e-05	0.000166	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Epirubicin—prostate cancer	1.12e-05	0.000166	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Mitoxantrone—prostate cancer	1.11e-05	0.000165	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Prednisone—prostate cancer	1.11e-05	0.000164	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Prednisone—prostate cancer	1.1e-05	0.000163	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	1.1e-05	0.00186	CbGpPWpGaD
Estradiol valerate/Dienogest—Palpitations—Capecitabine—prostate cancer	1.09e-05	0.000162	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Etoposide—prostate cancer	1.08e-05	0.00016	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	1.08e-05	0.00184	CbGpPWpGaD
Estradiol valerate/Dienogest—Asthenia—Mitoxantrone—prostate cancer	1.08e-05	0.00016	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Etoposide—prostate cancer	1.08e-05	0.00016	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Etoposide—prostate cancer	1.07e-05	0.000159	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Estradiol—prostate cancer	1.07e-05	0.000159	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Capecitabine—prostate cancer	1.05e-05	0.000155	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Docetaxel—prostate cancer	1.04e-05	0.000154	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Docetaxel—prostate cancer	1.04e-05	0.000154	CcSEcCtD
Estradiol valerate/Dienogest—Weight increased—Doxorubicin—prostate cancer	1.04e-05	0.000154	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Doxorubicin—prostate cancer	1.03e-05	0.000153	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Estradiol—prostate cancer	1.03e-05	0.000152	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Etoposide—prostate cancer	1.02e-05	0.000152	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Docetaxel—prostate cancer	1.02e-05	0.000151	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Estradiol—prostate cancer	1.02e-05	0.000151	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	1.02e-05	0.00173	CbGpPWpGaD
Estradiol valerate/Dienogest—Dermatitis—Estradiol—prostate cancer	1.02e-05	0.000151	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Estradiol—prostate cancer	1.01e-05	0.00015	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Capecitabine—prostate cancer	1.01e-05	0.00015	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	1.01e-05	0.00171	CbGpPWpGaD
Estradiol valerate/Dienogest—Angioedema—Prednisone—prostate cancer	1.01e-05	0.000149	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	1.01e-05	0.00171	CbGpPWpGaD
Estradiol valerate/Dienogest—Urticaria—Etoposide—prostate cancer	9.95e-06	0.000148	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Etoposide—prostate cancer	9.9e-06	0.000147	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Capecitabine—prostate cancer	9.89e-06	0.000147	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Epirubicin—prostate cancer	9.71e-06	0.000144	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Estradiol—prostate cancer	9.6e-06	0.000142	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	9.59e-06	0.00163	CbGpPWpGaD
Estradiol valerate/Dienogest—Vomiting—Mitoxantrone—prostate cancer	9.58e-06	0.000142	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Epirubicin—prostate cancer	9.53e-06	0.000141	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Mitoxantrone—prostate cancer	9.5e-06	0.000141	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Mitoxantrone—prostate cancer	9.49e-06	0.000141	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	9.49e-06	0.00161	CbGpPWpGaD
Estradiol valerate/Dienogest—Headache—Mitoxantrone—prostate cancer	9.44e-06	0.00014	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Epirubicin—prostate cancer	9.35e-06	0.000139	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Prednisone—prostate cancer	9.33e-06	0.000138	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Epirubicin—prostate cancer	9.24e-06	0.000137	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Etoposide—prostate cancer	9.23e-06	0.000137	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Epirubicin—prostate cancer	9.17e-06	0.000136	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Docetaxel—prostate cancer	9.16e-06	0.000136	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—HPGDS—prostate cancer	9.14e-06	0.00155	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	9.08e-06	0.00154	CbGpPWpGaD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Docetaxel—prostate cancer	8.99e-06	0.000133	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Etoposide—prostate cancer	8.99e-06	0.000133	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Doxorubicin—prostate cancer	8.99e-06	0.000133	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Prednisone—prostate cancer	8.98e-06	0.000133	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Prednisone—prostate cancer	8.98e-06	0.000133	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Docetaxel—prostate cancer	8.98e-06	0.000133	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	8.96e-06	0.00152	CbGpPWpGaD
Estradiol valerate/Dienogest—Nausea—Mitoxantrone—prostate cancer	8.95e-06	0.000133	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Epirubicin—prostate cancer	8.93e-06	0.000132	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Docetaxel—prostate cancer	8.9e-06	0.000132	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Capecitabine—prostate cancer	8.87e-06	0.000132	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—GSTT1—prostate cancer	8.87e-06	0.00151	CbGpPWpGaD
Estradiol valerate/Dienogest—Pruritus—Etoposide—prostate cancer	8.86e-06	0.000131	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Doxorubicin—prostate cancer	8.81e-06	0.000131	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Prednisone—prostate cancer	8.81e-06	0.000131	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	8.76e-06	0.00149	CbGpPWpGaD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Capecitabine—prostate cancer	8.7e-06	0.000129	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Capecitabine—prostate cancer	8.69e-06	0.000129	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Epirubicin—prostate cancer	8.66e-06	0.000128	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Doxorubicin—prostate cancer	8.65e-06	0.000128	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Capecitabine—prostate cancer	8.62e-06	0.000128	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Epirubicin—prostate cancer	8.6e-06	0.000128	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Doxorubicin—prostate cancer	8.55e-06	0.000127	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Docetaxel—prostate cancer	8.51e-06	0.000126	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Doxorubicin—prostate cancer	8.49e-06	0.000126	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Epirubicin—prostate cancer	8.48e-06	0.000126	CcSEcCtD
Estradiol valerate/Dienogest—Tension—Epirubicin—prostate cancer	8.44e-06	0.000125	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	8.41e-06	0.00143	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	8.39e-06	0.00142	CbGpPWpGaD
Estradiol valerate/Dienogest—Nervousness—Epirubicin—prostate cancer	8.36e-06	0.000124	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Etoposide—prostate cancer	8.28e-06	0.000123	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	8.28e-06	0.00141	CbGpPWpGaD
Estradiol valerate/Dienogest—Muscle spasms—Epirubicin—prostate cancer	8.27e-06	0.000123	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Doxorubicin—prostate cancer	8.26e-06	0.000123	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Capecitabine—prostate cancer	8.24e-06	0.000122	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Docetaxel—prostate cancer	8.23e-06	0.000122	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Doxorubicin—prostate cancer	8.01e-06	0.000119	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Capecitabine—prostate cancer	8.01e-06	0.000119	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—NCOA2—prostate cancer	8e-06	0.00136	CbGpPWpGaD
Estradiol valerate/Dienogest—Abdominal pain—Capecitabine—prostate cancer	7.97e-06	0.000118	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Etoposide—prostate cancer	7.97e-06	0.000118	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Doxorubicin—prostate cancer	7.96e-06	0.000118	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Prednisone—prostate cancer	7.9e-06	0.000117	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Etoposide—prostate cancer	7.9e-06	0.000117	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Etoposide—prostate cancer	7.89e-06	0.000117	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Etoposide—prostate cancer	7.85e-06	0.000116	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Doxorubicin—prostate cancer	7.85e-06	0.000116	CcSEcCtD
Estradiol valerate/Dienogest—Tension—Doxorubicin—prostate cancer	7.81e-06	0.000116	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Prednisone—prostate cancer	7.74e-06	0.000115	CcSEcCtD
Estradiol valerate/Dienogest—Nervousness—Doxorubicin—prostate cancer	7.73e-06	0.000115	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Docetaxel—prostate cancer	7.67e-06	0.000114	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Doxorubicin—prostate cancer	7.65e-06	0.000114	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Epirubicin—prostate cancer	7.6e-06	0.000113	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Docetaxel—prostate cancer	7.47e-06	0.000111	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	7.45e-06	0.00127	CbGpPWpGaD
Estradiol valerate/Dienogest—Nausea—Etoposide—prostate cancer	7.44e-06	0.00011	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Capecitabine—prostate cancer	7.43e-06	0.00011	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Docetaxel—prostate cancer	7.37e-06	0.000109	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	7.35e-06	0.00125	CbGpPWpGaD
Estradiol valerate/Dienogest—Gastrointestinal pain—Prednisone—prostate cancer	7.34e-06	0.000109	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Epirubicin—prostate cancer	7.3e-06	0.000108	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Capecitabine—prostate cancer	7.23e-06	0.000107	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Prednisone—prostate cancer	7.13e-06	0.000106	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Capecitabine—prostate cancer	7.13e-06	0.000106	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Prednisone—prostate cancer	7.1e-06	0.000105	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	7.06e-06	0.0012	CbGpPWpGaD
Estradiol valerate/Dienogest—Palpitations—Doxorubicin—prostate cancer	7.04e-06	0.000104	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Epirubicin—prostate cancer	7.02e-06	0.000104	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Epirubicin—prostate cancer	7.02e-06	0.000104	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	6.97e-06	0.00118	CbGpPWpGaD
Estradiol valerate/Dienogest—Nervous system disorder—Epirubicin—prostate cancer	6.89e-06	0.000102	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Docetaxel—prostate cancer	6.88e-06	0.000102	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—GGT1—prostate cancer	6.84e-06	0.00116	CbGpPWpGaD
Estradiol valerate/Dienogest—Anxiety—Doxorubicin—prostate cancer	6.75e-06	0.0001	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—NCOA1—prostate cancer	6.74e-06	0.00114	CbGpPWpGaD
Estradiol valerate/Dienogest—Dizziness—Capecitabine—prostate cancer	6.67e-06	9.89e-05	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	6.64e-06	0.00113	CbGpPWpGaD
Estradiol valerate/Dienogest—Vomiting—Docetaxel—prostate cancer	6.62e-06	9.82e-05	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Prednisone—prostate cancer	6.62e-06	9.81e-05	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Docetaxel—prostate cancer	6.56e-06	9.74e-05	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Docetaxel—prostate cancer	6.56e-06	9.73e-05	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	6.55e-06	0.00111	CbGpPWpGaD
Estradiol valerate/Dienogest—Headache—Docetaxel—prostate cancer	6.52e-06	9.67e-05	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Doxorubicin—prostate cancer	6.5e-06	9.64e-05	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Doxorubicin—prostate cancer	6.5e-06	9.64e-05	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Prednisone—prostate cancer	6.44e-06	9.55e-05	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—RXRA—prostate cancer	6.41e-06	0.00109	CbGpPWpGaD
Estradiol valerate/Dienogest—Vomiting—Capecitabine—prostate cancer	6.41e-06	9.51e-05	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Doxorubicin—prostate cancer	6.37e-06	9.45e-05	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Capecitabine—prostate cancer	6.36e-06	9.43e-05	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Prednisone—prostate cancer	6.35e-06	9.42e-05	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Capecitabine—prostate cancer	6.35e-06	9.42e-05	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Capecitabine—prostate cancer	6.31e-06	9.37e-05	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Docetaxel—prostate cancer	6.18e-06	9.17e-05	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Epirubicin—prostate cancer	6.18e-06	9.17e-05	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—COMT—prostate cancer	6.17e-06	0.00105	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—GSTP1—prostate cancer	6.15e-06	0.00104	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	6.09e-06	0.00103	CbGpPWpGaD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Epirubicin—prostate cancer	6.06e-06	8.99e-05	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	6.06e-06	0.00103	CbGpPWpGaD
Estradiol valerate/Dienogest—Fatigue—Epirubicin—prostate cancer	6.05e-06	8.98e-05	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Epirubicin—prostate cancer	6.01e-06	8.91e-05	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Capecitabine—prostate cancer	5.99e-06	8.88e-05	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Prednisone—prostate cancer	5.94e-06	8.81e-05	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Epirubicin—prostate cancer	5.74e-06	8.52e-05	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Doxorubicin—prostate cancer	5.72e-06	8.48e-05	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Prednisone—prostate cancer	5.71e-06	8.47e-05	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Prednisone—prostate cancer	5.66e-06	8.4e-05	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Prednisone—prostate cancer	5.66e-06	8.39e-05	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—GSTM1—prostate cancer	5.65e-06	0.000959	CbGpPWpGaD
Estradiol valerate/Dienogest—Headache—Prednisone—prostate cancer	5.63e-06	8.34e-05	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.61e-06	8.32e-05	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Doxorubicin—prostate cancer	5.6e-06	8.31e-05	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Epirubicin—prostate cancer	5.58e-06	8.27e-05	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	5.57e-06	0.000946	CbGpPWpGaD
Estradiol valerate/Dienogest—Pain—Doxorubicin—prostate cancer	5.56e-06	8.24e-05	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Epirubicin—prostate cancer	5.55e-06	8.23e-05	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	5.35e-06	0.000909	CbGpPWpGaD
Estradiol valerate/Dienogest—Nausea—Prednisone—prostate cancer	5.33e-06	7.91e-05	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Doxorubicin—prostate cancer	5.31e-06	7.88e-05	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—HAO1—prostate cancer	5.28e-06	0.000897	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	5.28e-06	0.000896	CbGpPWpGaD
Estradiol valerate/Dienogest—Hypersensitivity—Epirubicin—prostate cancer	5.17e-06	7.67e-05	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Doxorubicin—prostate cancer	5.16e-06	7.66e-05	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Doxorubicin—prostate cancer	5.14e-06	7.62e-05	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Epirubicin—prostate cancer	5.04e-06	7.47e-05	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Epirubicin—prostate cancer	4.97e-06	7.37e-05	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Doxorubicin—prostate cancer	4.79e-06	7.1e-05	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Doxorubicin—prostate cancer	4.66e-06	6.91e-05	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Epirubicin—prostate cancer	4.64e-06	6.89e-05	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Doxorubicin—prostate cancer	4.6e-06	6.82e-05	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Epirubicin—prostate cancer	4.47e-06	6.62e-05	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Epirubicin—prostate cancer	4.43e-06	6.57e-05	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Epirubicin—prostate cancer	4.42e-06	6.56e-05	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Epirubicin—prostate cancer	4.4e-06	6.52e-05	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—ADI1—prostate cancer	4.31e-06	0.000731	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—TST—prostate cancer	4.31e-06	0.000731	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PSAT1—prostate cancer	4.31e-06	0.000731	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GRHL1—prostate cancer	4.31e-06	0.000731	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CSAD—prostate cancer	4.31e-06	0.000731	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CBR1—prostate cancer	4.31e-06	0.000731	CbGpPWpGaD
Estradiol valerate/Dienogest—Dizziness—Doxorubicin—prostate cancer	4.3e-06	6.37e-05	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Epirubicin—prostate cancer	4.17e-06	6.19e-05	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Doxorubicin—prostate cancer	4.13e-06	6.13e-05	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Doxorubicin—prostate cancer	4.1e-06	6.08e-05	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Doxorubicin—prostate cancer	4.09e-06	6.07e-05	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Doxorubicin—prostate cancer	4.07e-06	6.04e-05	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—UGT2B17—prostate cancer	4e-06	0.00068	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—UGT2B15—prostate cancer	4e-06	0.00068	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GRHPR—prostate cancer	4e-06	0.00068	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CKMT2—prostate cancer	4e-06	0.00068	CbGpPWpGaD
Estradiol valerate/Dienogest—Nausea—Doxorubicin—prostate cancer	3.86e-06	5.72e-05	CcSEcCtD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GSTM3—prostate cancer	3.76e-06	0.000639	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—NAGLU—prostate cancer	3.76e-06	0.000639	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—AOX1—prostate cancer	3.76e-06	0.000639	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—SULT2B1—prostate cancer	3.76e-06	0.000639	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—RFK—prostate cancer	3.76e-06	0.000639	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—MBTPS1—prostate cancer	3.76e-06	0.000639	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PGAM2—prostate cancer	3.76e-06	0.000639	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CYP3A43—prostate cancer	3.57e-06	0.000606	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—AMACR—prostate cancer	3.57e-06	0.000606	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—NAT1—prostate cancer	3.57e-06	0.000606	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—SRD5A2—prostate cancer	3.57e-06	0.000606	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—DEGS1—prostate cancer	3.57e-06	0.000606	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—HSD17B1—prostate cancer	3.4e-06	0.000578	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—HPGD—prostate cancer	3.03e-06	0.000515	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—B4GALT4—prostate cancer	3.03e-06	0.000515	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—TNFRSF21—prostate cancer	2.85e-06	0.000484	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CYP7B1—prostate cancer	2.78e-06	0.000471	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—MTAP—prostate cancer	2.78e-06	0.000471	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—SULT1E1—prostate cancer	2.7e-06	0.000459	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—SRD5A1—prostate cancer	2.7e-06	0.000459	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—ACSL4—prostate cancer	2.58e-06	0.000438	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—HSD17B3—prostate cancer	2.58e-06	0.000438	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PHGDH—prostate cancer	2.47e-06	0.00042	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—ARG2—prostate cancer	2.47e-06	0.00042	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—UMPS—prostate cancer	2.47e-06	0.00042	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—LDHB—prostate cancer	2.43e-06	0.000412	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.38e-06	0.000404	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—TCN2—prostate cancer	2.3e-06	0.00039	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PDHA1—prostate cancer	2.3e-06	0.00039	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GSTA3—prostate cancer	2.3e-06	0.00039	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—UCP3—prostate cancer	2.3e-06	0.00039	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.19e-06	0.000372	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.19e-06	0.000372	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GSTA4—prostate cancer	2.1e-06	0.000357	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.1e-06	0.000357	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GSTA2—prostate cancer	2.05e-06	0.000348	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—ABCG5—prostate cancer	2.02e-06	0.000344	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.02e-06	0.000344	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GSTA1—prostate cancer	1.98e-06	0.000336	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.96e-06	0.000332	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—NAT2—prostate cancer	1.96e-06	0.000332	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GSTO1—prostate cancer	1.96e-06	0.000332	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PLCB2—prostate cancer	1.87e-06	0.000318	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—LRP2—prostate cancer	1.87e-06	0.000318	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.87e-06	0.000318	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—P4HB—prostate cancer	1.84e-06	0.000312	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.79e-06	0.000304	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.74e-06	0.000296	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—MED12—prostate cancer	1.71e-06	0.000291	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GNG5—prostate cancer	1.7e-06	0.000289	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—NCOA3—prostate cancer	1.64e-06	0.000278	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—HPGDS—prostate cancer	1.56e-06	0.000265	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.55e-06	0.000264	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—ACHE—prostate cancer	1.52e-06	0.000257	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GSTT1—prostate cancer	1.52e-06	0.000257	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.5e-06	0.000254	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.46e-06	0.000248	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PRKACB—prostate cancer	1.45e-06	0.000246	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.44e-06	0.000244	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—NCOA2—prostate cancer	1.37e-06	0.000232	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.3e-06	0.000221	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.27e-06	0.000216	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—NQO1—prostate cancer	1.26e-06	0.000214	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—TH—prostate cancer	1.24e-06	0.000211	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.21e-06	0.000205	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GGT1—prostate cancer	1.17e-06	0.000199	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—NCOA1—prostate cancer	1.15e-06	0.000196	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.14e-06	0.000193	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—RXRA—prostate cancer	1.1e-06	0.000186	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—COMT—prostate cancer	1.06e-06	0.000179	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GSTP1—prostate cancer	1.05e-06	0.000178	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—ITPR1—prostate cancer	1.03e-06	0.000176	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—TYMS—prostate cancer	9.77e-07	0.000166	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—GSTM1—prostate cancer	9.66e-07	0.000164	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—LPL—prostate cancer	9.48e-07	0.000161	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.16e-07	0.000155	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—ERCC2—prostate cancer	9.08e-07	0.000154	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—MTHFR—prostate cancer	8.54e-07	0.000145	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PPARA—prostate cancer	8.37e-07	0.000142	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CAV1—prostate cancer	7.87e-07	0.000134	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.17e-07	0.000122	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—INS—prostate cancer	6.79e-07	0.000115	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—CREBBP—prostate cancer	6.65e-07	0.000113	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.3e-07	0.000107	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—NOS3—prostate cancer	5.95e-07	0.000101	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.5e-07	9.33e-05	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PTGS2—prostate cancer	5.44e-07	9.24e-05	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PTEN—prostate cancer	4.75e-07	8.06e-05	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—EP300—prostate cancer	4.53e-07	7.69e-05	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.35e-07	5.69e-05	CbGpPWpGaD
Estradiol valerate/Dienogest—CYP3A4—Metabolism—AKT1—prostate cancer	2.74e-07	4.65e-05	CbGpPWpGaD
